Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;84:1354-1363

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eisenhofer, G.
Right arrow Articles by Esler, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eisenhofer, G.
Right arrow Articles by Esler, M. D.

Circulation, Vol 84, 1354-1363, Copyright © 1991 by American Heart Association


ARTICLES

Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog

G Eisenhofer, JJ Smolich, HS Cox and MD Esler
Baker Medical Research Institute, Prahran, Victoria, Australia.

BACKGROUND. Reuptake of norepinephrine by cardiac sympathetic nerves before and during two levels of electrical stimulation of the left ansa subclavia was estimated in anesthetized dogs from the cardiac production of dihydroxyphenylglycol (DHPG), the intraneuronal metabolite of norepinephrine. METHODS AND RESULTS. The method depended on the effects of neuronal uptake blockade with desipramine on the cardiac production of [3H]DHPG from intravenously infused [3H]norepinephrine. The ratio of the desipramine-induced decrease in the cardiac extraction of [3H]norepinephrine to the production of [3H]DHPG was used to transform the cardiac production of DHPG from recaptured norepinephrine into a rate for norepinephrine reuptake. Cardiac spillover of norepinephrine into plasma increased from 49 +/- 12 to 205 +/- 40 and 451 +/- 118 pmol/min during sympathetic activation. Cardiac DHPG production increased from 108 +/- 18 to 166 +/- 34 and 240 +/- 47 pmol/min. Desipramine decreased resting cardiac DHPG production by 20% and completely blocked the stimulation-induced increase. Thus, most (80%) cardiac DHPG produced at rest was derived from norepinephrine leaking from storage vesicles. This amount remained constant, and that derived from recaptured norepinephrine increased during sympathetic activation. The cardiac extraction of [3H]norepinephrine (126,000 dpm/min) and production of [3H]DHPG (3,790 dpm/min) were decreased by 55-57% after desipramine. Thus, only 3% of the norepinephrine recaptured by cardiac sympathetic nerves appeared in plasma as DHPG. The remainder was sequestered into storage vesicles (more than 94%) or ultimately formed metabolites other than DHPG (less than 3%). Reuptake of norepinephrine by cardiac sympathetic nerves was 1,188 +/- 476 pmol/min and increased in parallel with cardiac norepinephrine spillover to 4,182 +/- 1,982 and 6,594 +/- 2,241 pmol/min during sympathetic stimulation. CONCLUSIONS. Of the norepinephrine released by cardiac sympathetic nerves, 16-fold more was recaptured than entered plasma. Combined estimation of norepinephrine reuptake and spillover offers an approach to assess the efficiency of neuronal reuptake in disorders of cardiac function.


This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. N. Andrews, A. E. Bharucha, M. Camilleri, P. A. Low, B. Seide, D. Burton, K. Baxter, and A. R. Zinsmeister
Nitrergic contribution to gastric relaxation induced by glucagon-like peptide-1 (GLP-1) in healthy adults
Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1359 - G1365.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
G. Eisenhofer, I. J. Kopin, and D. S. Goldstein
Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine
Pharmacol. Rev., September 1, 2004; 56(3): 331 - 349.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Akiyama and T. Yamazaki
Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion
Cardiovasc Res, January 1, 2001; 49(1): 78 - 85.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. W. Lameris, A. H. van den Meiracker, F. Boomsma, G. Alberts, S. de Zeeuw, D. J. Duncker, P. D. Verdouw, and A. J. M. I.'t Veld
Catecholamine handling in the porcine heart: a microdialysis approach
Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1562 - H1569.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. E. Newton, E. R. Azevedo, and J. D. Parker
Inotropic and Sympathetic Responses to the Intracoronary Infusion of a ß2-Receptor Agonist : A Human In Vivo Study
Circulation, May 11, 1999; 99(18): 2402 - 2407.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Mokrane and R. Nadeau
Dynamics of heart rate response to sympathetic nerve stimulation
Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H995 - H1001.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Eisenhofer, B. Rundqvist, and P. Friberg
Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R626 - R634.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Eisenhofer, P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler
Cardiac Sympathetic Nerve Function in Congestive Heart Failure
Circulation, May 1, 1996; 93(9): 1667 - 1676.
[Abstract] [Full Text]